• Cannabidiol Modulates Endocannabinoids to Alleviate Orofacia

  2026-06-29

  This study demonstrates that cannabidiol (CBD) robustly reduces both sensory and affective components of orofacial inflammatory pain in mice by targeting peripheral and central endocannabinoid pathways, including FAAH downregulation and anandamide elevation. The findings provide mechanistic insight into CBD’s multi-modal analgesic effects and underscore the translational potential of endocannabinoid modulation for comprehensive pain management.

• Ginsenoside Rg1 Restores Gut-Brain-Immune Axis After Anesthe

  2026-06-29

  The referenced study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neuroimmune and behavioral deficits induced by prolonged isoflurane anesthesia in mice. These findings highlight a regulatory T cell-dependent mechanism linking gut barrier integrity, systemic inflammation, and hippocampal function, providing a mechanistic basis for Rg1’s neuroprotective action in perioperative settings.

• Actinomycin D in Cellular Stress Research: Beyond Cancer Mod

  2026-06-28

  Explore how Actinomycin D advances the study of apoptosis induction, transcriptional stress, and DNA damage response in cellular models. This comprehensive analysis reveals novel assay strategies and practical insights that go beyond its established role in cancer research.

• 3-Methyladenine in Vacuolization and Cell Death: New Autopha

  2026-06-27

  Explore the nuanced role of 3-Methyladenine in autophagy research, with a focus on cytoplasmic vacuolization and cell death pathways. This article provides a fresh, in-depth analysis grounded in recent discoveries and advanced assay considerations.

• Maraviroc (UK-427857): Applied Protocols in HIV and RA Model

  2026-06-26

  Maraviroc (UK-427857) is a benchmark CCR5 antagonist, uniquely enabling both HIV-1 entry inhibition and novel immunological applications such as targeted delivery in rheumatoid arthritis models. This article unpacks validated workflows, protocol enhancements, and troubleshooting strategies for maximizing Maraviroc's translational impact in cell-based and animal studies.

• FXR Protein LLPS Drives DMV Clustering in β-Coronavirus Repl

  2026-06-26

  Li et al. (2024) uncover that fragile X–related (FXR) proteins facilitate β-coronavirus proliferation by organizing double-membrane vesicle (DMV) clusters via liquid–liquid phase separation (LLPS). This mechanistic insight advances our understanding of viral replication organelle spatial organization and highlights new intervention points in coronavirus biology.

• Vidarabine Monohydrate: Optimizing Antiviral Workflows in Re

  2026-06-25

  Vidarabine monohydrate (Spongoadenosine monohydrate) from APExBIO delivers unmatched reliability for researchers studying viral DNA synthesis inhibition. This guide details evidence-backed workflows, advanced applications in herpes simplex virus models, and expert troubleshooting to maximize reproducibility and data integrity.

• Moxidectin Potentiates Polyenes via Ergosterol Upregulation

  2026-06-25

  A recent study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, enhances the antifungal activity of polyene drugs against Candida albicans by upregulating ergosterol biosynthesis. This mechanistic synergy not only improves therapeutic efficacy in preclinical oral candidiasis models but also suggests new avenues for combating drug resistance in fungal infections.

• 10074-G5 (SKU C5722): Reliable c-Myc Inhibition for Cancer R

  2026-06-24

  This article delivers scenario-driven, evidence-based guidance for biomedical researchers using 10074-G5 (SKU C5722), a validated c-Myc inhibitor, in cancer research workflows. By integrating quantitative data and real laboratory challenges, it shows how 10074-G5 underpins reproducibility and protocol fidelity in cell viability, apoptosis, and tumor regression studies.

• Practical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-06-23

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables efficient, high-yield synthesis of Cy3-labeled RNA probes for fluorescence-based detection methods such as in situ hybridization and Northern blotting. It is designed for research applications requiring sensitive RNA detection and is not intended for diagnostic or therapeutic workflows. Users should adhere strictly to protocol parameters and recommended use-cases to ensure reliability.

• Machine Learning-Guided LNPs for mRNA Delivery to Microglia

  2026-06-23

  This study presents a machine learning-driven approach to design lipid nanoparticles (LNPs) for targeted mRNA delivery that modulates hyperactivated microglia. By integrating a large LNP library, morphometric cell profiling, and predictive modeling, the work lays a foundation for more precise immunomodulatory therapies in neuroinflammatory disorders.

• Dual-Action p38α MAPK Inhibitors Modulate Dephosphorylation

  2026-06-22

  The reference study uncovers a new mechanism by which certain kinase inhibitors not only block p38α MAPK activity but also accelerate its dephosphorylation by phosphatases. This dual-action property offers a conceptual advance for designing more selective and potent inhibitors to modulate cytokine signaling, with direct implications for inflammation and autoimmune disease research.

• Substance P: Advanced Spectral Assay Strategies & Bioaerosol

  2026-06-22

  Explore the multifaceted role of Substance P as a tachykinin neuropeptide in pain, inflammation, and bioaerosol detection. This article uniquely integrates advanced assay design with spectral interference mitigation, unlocking new research capabilities.

• AMG 487: Potent CXCR3 Antagonist for Macrophage Polarization

  2026-06-21

  AMG 487 is a highly selective CXCR3 antagonist that enables precise inhibition of CXCL10-CXCR3 signaling and macrophage polarization. Peer-reviewed studies confirm its nanomolar potency in cell migration and autophagy modulation. This compound is foundational for dissecting context-dependent inflammatory responses.

• Evaluating Drug Responses in Cancer: In Vitro Methodological

  2026-06-20

  The referenced dissertation critically examines how standard in vitro methods distinguish between cancer cell death and proliferation arrest when evaluating anti-cancer drug responses. By dissecting fractional viability versus relative viability, the study clarifies their distinct biological readouts and offers nuanced recommendations for experimental design, optimizing the interpretation of drug-induced effects in cancer research.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page